VivoSense is an agile end-to-end scientific solutions company measuring patient outcomes by developing novel digital endpoints from ActiGraph wearable sensor data. Our hypothesis-driven framework provides analytical and clinical validation leading to FDA approval. We are the first analytics company to develop novel digital biomarkers from wearable sensor data which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials.


A Proven and Repeatable Approach To Digital Outcome Measures and Endpoints


  • 10+ Years’ Experience: Deliver end-to-end digital biomarkers
  • Wearable Sensor Agnostic: Integrate with any sensor, anywhere, anytime
  • Drive FDA Validation: Provide evidence in regulatory decision-making
  • Powerful Analytics Software: Collect, visualize, and analyze real-world data